Data-driven spatio-temporal modelling of glioblastoma

Mathematical oncology provides unique and invaluable insights into tumour growth on both the microscopic and macroscopic levels. This review presents state-of-the-art modelling techniques and focuses on their role in understanding glioblastoma, a malignant form of brain cancer. For each approach, we summarise the scope, drawbacks, and assets. We highlight the potential clinical applications of each modelling technique and discuss the connections between the mathematical models and the molecular and imaging data used to inform them. By doing so, we aim to prime cancer researchers with current and emerging computational tools for understanding tumour progression. Finally, by providing an in-depth picture of the different modelling techniques, we also aim to assist researchers who seek to build and develop their own models and the associated inference frameworks.Comment: 30 pages, 3 figures, 3 table

Mathematical Modelling of Glioblastomas Invasion within the Brain:A 3D Multi-Scale Moving-Boundary Approach

International audienceBrain-related experiments are limited by nature, and so biological insights are often limited or absent. This is particularly problematic in the context of brain cancers, which have very poor survival rates. To generate and test new biological hypotheses, researchers have started using mathematical models that can simulate tumour evolution. However, most of these models focus on single-scale 2D cell dynamics, and cannot capture the complex multi-scale tumour invasion patterns in 3D brains. A particular role in these invasion patterns is likely played by the distribution of micro-fibres. To investigate the explicit role of brain micro-fibres in 3D invading tumours, in this study, we extended a previously introduced 2D multi-scale moving-boundary framework to take into account 3D multi-scale tumour dynamics. T1 weighted and DTI scans are used as initial conditions for our model, and to parametrise the diffusion tensor. Numerical results show that including an anisotropic diffusion term may lead in some cases (for specific micro-fibre distributions) to significant changes in tumour morphology, while in other cases, it has no effect. This may be caused by the underlying brain structure and its microscopic fibre representation, which seems to influence cancer-invasion patterns through the underlying cell-adhesion process that overshadows the diffusion process

Addressing current challenges in cancer immunotherapy with mathematical and computational modeling

The goal of cancer immunotherapy is to boost a patient's immune response to a tumor. Yet, the design of an effective immunotherapy is complicated by various factors, including a potentially immunosuppressive tumor microenvironment, immune-modulating effects of conventional treatments, and therapy-related toxicities. These complexities can be incorporated into mathematical and computational models of cancer immunotherapy that can then be used to aid in rational therapy design. In this review, we survey modeling approaches under the umbrella of the major challenges facing immunotherapy development, which encompass tumor classification, optimal treatment scheduling, and combination therapy design. Although overlapping, each challenge has presented unique opportunities for modelers to make contributions using analytical and numerical analysis of model outcomes, as well as optimization algorithms. We discuss several examples of models that have grown in complexity as more biological information has become available, showcasing how model development is a dynamic process interlinked with the rapid advances in tumor-immune biology. We conclude the review with recommendations for modelers both with respect to methodology and biological direction that might help keep modelers at the forefront of cancer immunotherapy development.Comment: Accepted for publication in the Journal of the Royal Society Interfac

Patient-specific, mechanistic models of tumor growth incorporating artificial intelligence and big data

Despite the remarkable advances in cancer diagnosis, treatment, and management that have occurred over the past decade, malignant tumors remain a major public health problem. Further progress in combating cancer may be enabled by personalizing the delivery of therapies according to the predicted response for each individual patient. The design of personalized therapies requires patient-specific information integrated into an appropriate mathematical model of tumor response. A fundamental barrier to realizing this paradigm is the current lack of a rigorous, yet practical, mathematical theory of tumor initiation, development, invasion, and response to therapy. In this review, we begin by providing an overview of different approaches to modeling tumor growth and treatment, including mechanistic as well as data-driven models based on ``big data" and artificial intelligence. Next, we present illustrative examples of mathematical models manifesting their utility and discussing the limitations of stand-alone mechanistic and data-driven models. We further discuss the potential of mechanistic models for not only predicting, but also optimizing response to therapy on a patient-specific basis. We then discuss current efforts and future possibilities to integrate mechanistic and data-driven models. We conclude by proposing five fundamental challenges that must be addressed to fully realize personalized care for cancer patients driven by computational models

Predicting cell behaviour parameters from glioblastoma on a chip images. A deep learning approach

The broad possibilities offered by microfluidic devices in relation to massive data monitoring and acquisition open the door to the use of deep learning technologies in a very promising field: cell culture monitoring. In this work, we develop a methodology for parameter identification in cell culture from fluorescence images using Convolutional Neural Networks (CNN). We apply this methodology to the in vitro study of glioblastoma (GBM), the most common, aggressive and lethal primary brain tumour. In particular, the aim is to predict the three parameters defining the go or grow GBM behaviour, which is determinant for the tumour prognosis and response to treatment. The data used to train the network are obtained from a mathematical model, previously validated with in vitro experimental results. The resulting CNN provides remarkably accurate predictions (Pearson''s ¿ > 0.99 for all the parameters). Besides, it proves to be sound, to filter noise and to generalise. After training and validation with synthetic data, we predict the parameters corresponding to a real image of a microfluidic experiment. The obtained results show good performance of the CNN. The proposed technique may set the first steps towards patient-specific tools, able to predict in real-time the tumour evolution for each particular patient, thanks to a combined in vitro-in silico approach. © 2021 The Author(s

Mathematical models for glioma growh and migration inside the brain

284 p.Los gliomas forman el subtipo más prevalente, agresivo e invasivo de tumores cerebrales primarios,caracterizados por una rápida proliferación celular y una elevada capacidad de infiltración. A pesar de los avances de la investigación clínica, estos tumores suelen ser resistentes al tratamiento; la supervivencia media oscila entre 9 y 12 meses, siendo la recurrencia la principal causa de mortalidad.La migración y la invasión de los gliomas en el cerebro son fenómenos complejos y aún se desconocen varios de los mecanismos subyacentes que guían la progresión de estos tumores.En esta tesis, proponemos varios modelos matemáticos para estudiar diversos aspectos de la progresión del glioma en relación con las escalas microscópicas y macroscópicas que caracterizan este proceso. Considerar el carácter intrínsico multiescala de la evolución del glioma permite definir modelos basados en sistemas dinámicos, ecuaciones cinéticas y EDP macroscópicas con diferentes roles dependiendo de los fenómenos a estudiar. Uno de los objetivos principales de esta tesis es integrar datos biológicos y clínicos con los modelos matemáticos. Los datos experimentales utilizados se han obtenido de imágenes por resonancia magnética, de imágenes con tensor de difusión del cerebro humano y de análisis de inmunofluorescencia in vivo de distribuciones de varias proteínas en Drosophila, un modelo fiable para el estudio de la dinámica del glioblastoma.Analizamos las características de anisotropía del tejido nervioso, utilizando los datos del tensor de difusión, y la influencia de la estructura de las fibras en la dinámica de las células tumorales.Mostramos cómo la red de fibras guía la migración celular a lo largo de rutas preferenciales,reproduciendo los patrones ramificados y heterogéneos típicos de la evolución del glioma; asimismo,demostramos cómo los tratamientos multimodales pueden reducir este comportamiento.Estudiamos la interdependencia entre la acidez del microambiente y la vascularización en el proceso de angiogénesis tumoral. Para ello, construimos un modelo capaz de reproducir la influencia de estos mecanismos en el desarrollo de la heterogeneidad intratumoral y de características típicas de la progresión del glioma relacionadas con la hipoxia (e.g. la necrosis). Este estudio permite formular una clasificación de los tumores basada en el nivel de necrosis, así como la investigación de terapias multimodales que incluyan efectos antiangiogénicos.Investigamos la influencia de las protrusiones celulares desde una perspectiva no local.Analizamos su rol en el fenómeno de la guía por contacto y en la manifestación de efectos colaborativos o competitivos entre dos estímulos que determinan cambios de dirección de la velocidad celular.Utilizando el análisis experimental de las distribuciones de varias proteínas, evaluamos la relación de las protrusiones celulares con las integrinas y las proteasas como principales mecanismos de progresión del glioblastoma. Mostramos cómo las interacciones bioquímicas y biomecánicas de estos agentes dan como resultado el desarrollo de frentes de propagación tumoral, que pueden presentar una evolución dinámica y heterogénea en relación a los cambios ambientales.bcam:basque center for applied mathematics; La Caixa Foundatio

Hybrid data-based modelling in oncology: successes, challenges and hopes

International audienceIn this review we make the statement that hybrid models in oncology are required as a mean for enhanced data integration. In the context of systems oncology, experimental and clinical data need to be at the heart of the models developments from conception to validation to ensure a relevant use of the models in the clinical context. The main applications pursued are to improve diagnosis and to optimize therapies.We first present the Successes achieved thanks to hybrid modelling approaches to advance knowledge, treatments or drug discovery. Then we present the Challenges than need to be addressed to allow for a better integration of the model parts and of the data into the models. And Finally, the Hopes with a focus towards making personalised medicine a reality. Mathematics Subject Classification. 35Q92, 68U20, 68T05, 92-08, 92B05